VENUVENUAMEX
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+81.6%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+81.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$48.27M+39.9%
2024$34.50M+116.2%
2023$15.96M+97.9%
2022$8.06M-